ROS signaling in systemic and cellular responses to chronic intermittent hypoxia

Antioxidants and Redox Signaling

Volumn 9, Issue 9, 2007, Pages 1397-1403

  Prabhakar, Nanduri R ^a   Kumar, Ganesh K ^a   Nanduri, Jayasri ^a   Semenza, Gregg L ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; NEUROTRANSMITTER; NEUROTROPHIC FACTOR; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR;

APNEA; ARTERIAL OXYGEN TENSION; CAROTID BODY; CHEMORECEPTOR; CHRONIC INTERMITTENT HYPOXIA; COGNITION; HUMAN; HYPERTENSION; HYPOXIA; MORBIDITY; NEUROTRANSMITTER RELEASE; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; RECURRENT DISEASE; REVIEW; SECOND MESSENGER; SIGNAL TRANSDUCTION; SLEEP; SLEEP DISORDERED BREATHING; SYSTEMATIC REVIEW;

ANOXIA; CAROTID BODY; CHRONIC DISEASE; HUMANS; REACTIVE OXYGEN SPECIES; SIGNAL TRANSDUCTION; SLEEP APNEA SYNDROMES;

EID: 34547889942     PISSN: 15230864     EISSN: None     Source Type: Journal    
DOI: 10.1089/ars.2007.1732     Document Type: Review

References (52)

1. Baker-Herman TL, Fuller DD, Bavis RW, Zabka AG, Golder FJ, Doperalski NJ, Johnson RA, Watters JJ, and Mitchell GS. BDNF is necessary and sufficient for spinal respiratory plasticity following intermittent hypoxia. Nat Neurosci 7: 48-55, 2004.
2. Barcelo A, Barbe F, de la Pena M, Vila M, Perez G, Pierola J, Duran J, and Agusti AG. Antioxidant status in patients with sleep apnoea and impact of continuous positive airway pressure treatment. Eur Respir J 27: 756-760, 2006.
3. Bao G, Metreveli N, Li R, Taylor A, and Fletcher EC. Blood pressure response to chronic episodic hypoxia: role of the sympathetic nervous system. J Appl Physiol 83: 95-101, 1997.
4. Carpagnano GE, Kharitonov SA, Resta O, Foschino-Barbaro MP, Gramiccioni E, and Barnes PJ. 8-Isoprostane, a marker of oxidative stress, is increased in exhaled breath condensate of patients with obstructive sleep apnea after night and is reduced by continuous positive airway pressure therapy. Chest 124: 1386-1392, 2003.
5. Cistulli PA and Sullivan CE. Pathophysiology of sleep apnea. In: Sleep and breathing, edited by Saunders NA and Sullivan CE. New York: Dekker, 1994, pp. 405-448.
6. Douglas NJ and Engleman HM. Effects of CPAP on vigilance and related functions in patients with the sleep apnea/hypopnea syndrome. Sleep 23: S147-S149, 2000.
7. Dyugovskaya L, Lavie P, and Lavie L. Increased adhesion molecules expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165: 934-939, 2002.
8. Gardner PR, Nguyen DD, and White CW. Aconitase is a sensitive and critical target of oxygen poisoning in cultured mammalian cells and in rat lungs. Proc Natl Acad Sci U S A 91: 12248-12252, 1994.
9. Gonzalez C, Agapito MT, Rocher A, Gonzalez-Martin MC, Vega-Agapito V, Gomez-Nino A, Rigual R, Castaneda J, and Obeso A. Chemoreception in the context of the general biology of ROS. Respir Physiol Neurobiol 2007; [Epub ahead of print]
10. Grebe M, Eisele HJ, Weissmann N, Schaefer C, Tillmanns H, Seeger W, and Schulz R. Antioxidant vitamin C improves endothelial function in obstructive sleep apnea. Am J Respir Crit Care Med 173: 897-901, 2006.
11. Greenberg HE, Sica AL, Scharf SM, and Ruggiero DA. Expression of c-fos in the rat brainstem after chronic intermittent hypoxia. Brain Res 816: 638-645, 1999.
12. Jelev A, Sood S, Liu H, Nolan P, and Horner RL. Microdialysis perfusion of 5-HT into hypoglossal motor nucleus differentially modulates genioglossus activity across natural sleep-wake states in rats. J Physiol 532: 467-481, 2001.
13. Jordan W, Cohrs S, Degner D, Meier A, Rodenbeck A, Mayer G, Pilz J, Ruther E, Kornhuber J, and Bleich S. Evaluation of oxidative stress measurements in obstructive sleep apnea syndrome. J Neural Transm 113: 239-254, 2006.
14. Kara T, Narkiewicz K, and Somers VK. Chemoreflexes: physiology and clinical implications. Acta Physiol Scand 177: 377-384, 2003.
15. Keating DJ, Rychkov GY, and Roberts ML. Oxygen sensitivity in the sheep adrenal medulla: role of SK channels. Am J Physiol Cell Physiol 281: C1434-1441, 2001.
16. Kheirandish L, Row BW, Li RC, Brittian KR, and Gozal D. Apolipoprotein E-deficient mice exhibit increased vulnerability to intermittent hypoxia-induced spatial learning deficits. Sleep 28: 1412-1417, 2005.
17. Kim DK, Natarajan N, Prabhakar NR, and Kumar GK. Facilitation of dopamine and acetylcholine release by intermittent hypoxia in PC12 cells: involvement of calcium and reactive oxygen species. J Appl Physiol 96: 1206-1215, 2004.
18. Kubin L, Tojima H, Reignier C, Pack AI, and Davies RO. Interaction of serotonergic excitatory drive to hypoglossal motoneurons with carbachol-induced, REM sleep-like atonia. Sleep 19: 187-195, 1996.
19. Kumar GK, Kim DK, Lee MS, Ramachandran R, and Prabhakar NR. Activation of tyrosine hydroxylase by intermittent hypoxia: involvement of serine phosphorylation. J Appl Physiol 95: 536-544, 2003.
20. Kumar GK, Rai V, Sharma SD, Ramakrishnan DP, Peng YJ, Souvannakitti D, and Prabhakar NR. Chronic intermittent hypoxia induces hypoxia-evoked catecholamine efflux in adult rat adrenal medulla via oxidative stress. J Physiol 575: 229-239, 2006.
21. Lavie L, Vishnevsky A, and Lavie P. Evidence for lipid peroxidation in obstructive sleep apnea. Sleep 27: 123-128, 2004.
22. Ling L, Fuller DD, Bach KB, Kinkead R, Olson EB Jr, and Mitchell GS. Chronic intermittent hypoxia elicits serotonin-dependent plasticity in the central neural control of breathing. J Neurosci 21: 5381-5388, 2001.
23. Mitchell GS and Johnson SM. Neuroplasticity in respiratory motor control. J Appl Physiol 94: 358-374, 2003.
24. Montgomery-Downs HE, Krishna J, Roberts LJ 2nd, and Gozal D. Urinary F(2)-isoprostane metabolite levels in children with sleep-disordered breathing. Sleep Breath 10: 211-215, 2006.
25. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D'Agostino RB, Newman AB, Lebowitz MD, and Pickering TG. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study: Sleep Heart Health Study. JAMA 283: 1829-1836, 2000.
26. Narkiewicz K, van de Borne PJ, Pesek CA, Dyken ME, Montano N, and Somers VK. Selective potentiation of peripheral chemoreflex sensitivity in obstructive sleep apnea. Circulation 99: 1183-1189, 1999.
27. Patel SR, White DP, Malhotra A, Stanchina ML, and Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch Intern Med 163: 565-571, 2003.
28. Peng YJ and Prabhakar NR. Reactive oxygen species in the plasticity of respiratory behavior elicited by chronic intermittent hypoxia. J Appl Physiol 94: 2342-2349, 2003.
29. Peng YJ and Prabhakar NR. Effect of two paradigms of chronic intermittent hypoxia on carotid body sensory activity. J Appl Physiol 96: 1236-1242, 2004.
30. Peng YJ, Overholt JL, Kline D, Kumar GK, and Prabhakar NR. Induction of sensory long-term facilitation in the carotid body by intermittent hypoxia: implications for recurrent apneas. Proc Natl Acad Sci U S A 100: 10073-10078, 2003.
31. Peng YJ, Yuan G, Ramakrishnan D, Sharma SD, Bosch-Marce M, Kumar GK, Semenza GL, and Prabhakar NR. Heterozygous HIF-1alpha deficiency impairs carotid body-mediated systemic responses and reactive oxygen species generation in mice exposed to intermittent hypoxia. J Physiol 577: 705-716, 2006.
32. Poets CF, Samuels MP, and Southall DP. Epidemiology and pathophysiology of apnoea of prematurity. Biol Neonate 65: 211-219, 1994.
33. 2 sensors and multiple transmitters? Exp Physiol 91: 17-23, 2006.
34. Prabhakar NR, Peng YJ, Jacono FJ, Kumar GK, and Dick TE. Cardiovascular alterations by chronic intermittent hypoxia: importance of carotid body chemoreflexes. Clin Exp Pharmacol Physiol 32: 447-449, 2005.
35. Rey S, Del Rio R, Alcayaga J and Iturriaga R. Chronic intermittent hypoxia enhances cat chemosensory and ventilatory responses to hypoxia. J Physiol 560: 577-586, 2004.
36. Row BW, Liu R, Xu W, Kheirandish L, and Gozal D. Intermittent hypoxia is associated with oxidative stress and spatial learning deficits in the rat. Am J Respir Crit Care Med 167: 1548-1553, 2003.
37. Sauter C, Asenbaum S, Popovic R, Bauer H, Lamm C, Klosch G, and Zeitlhofer J. Excessive daytime sleepiness in patients suffering from different levels of obstructive sleep apnoea syndrome. J Sleep Res 9: 293-301, 2000.
38. Schulz R, Mahmoudi S, Hattar K, Sibelius U, Olschewski H, Mayer K, Seeger W, and Grimminger F. Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162: 566-570, 2000.
39. Sica AL, Greenberg HE, Ruggiero DA, and Scharf SM. Chronic-intermittent hypoxia: a model of sympathetic activation in the rat. Respir Physiol 121: 173-184, 2000.
40. Semenza GL. Regulation of mammalian O2 homeostasis by hypoxia-inducible factor 1. Annu Rev Cell Dev Biol 15: 551-578, 1999.
41. Semenza GL and Prabhakar NR. HIF-1-dependent respiratory, cardiovascular and redox responses to chronic intermittent hypoxia. Antioxid Redox Signal (in press).
42. Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Nieto J, O'Connor GT, Boland LL, Schwartz JE, and Samet JM. Sleep-disordered breathing and cardiovascular disease. Am J Respir Crit Care Med 163:19-25, 2001.
43. Thompson RJ, Jackson A, and Nurse CA. Developmental loss of hypoxic chemo-sensitivity in rat adrenomedullary chromaffin cells. J Physiol 498: 503-510, 1997.
44. Veasey SC. Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential. Am J Respir Med 2: 21-29, 2003.
45. Veasey SC, Davis C, Zhan G, Hsu YJ, Fenik P, Pratico D, and Gow AJ. Long-term intermittent hypoxia in mice: protracted hypersomnolence with oxidative injury to sleep-wake brain regions. Sleep 27: 194-201, 2004.
46. Veasey SC, Zhan G, Fenik P, and Pratico D. Long-term intermittent hypoxia: reduced excitatory hypoglossal nerve output. Am J Respir Crit Care Med 170: 665-672, 2004.
47. Wang H, Yuan G, Prabhakar NR, Boswell M, and Katz DM. Secretion of brain-derived neurotrophic factor from PC12 cells in response to oxidative stress requires autocrine dopamine signaling. J Neurochem 96: 694-705, 2006.
48. Yamauchi M, Nakano H, Maekawa J, Okamoto Y, Ohnishi Y, Suzuki T, and Kimura H. Oxidative stress in obstructive sleep apnea. Chest 127: 1674-1679, 2005.
49. Young T, Palta M, Dempsey J, Skatrud J, Weber S, and Badr S. The occurrence of sleep-disordered breathing among middle-aged adults. N Engl J Med 328: 1230-1235, 1993.
50. Yuan G, Adhikary G, McCormick AA, Holcroft JJ, Kumar GK, and Prabhakar NR. Role of oxidative stress in intermittent hypoxia-induced immediate early gene activation in rat PC12 cells. J Physiol 557: 773-783, 2004.
51. 2+/calmodulin kinase-dependent activation of hypoxia inducible factor 1 transcriptional activity in cells subjected to intermittent hypoxia. J Biol Chem 280: 4321-4328, 2005.
52. Zhan G, Serrano F, Fenik P, Hsu R, Kong L, Pratico D, Klann E, and Veasey SC. NADPH oxidase mediates hypersomnolence and brain oxidative injury in a murine model of sleep apnea. Am J Respir Crit Care Med 172: 921-929, 2005.